Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial

Authors: Bielicki JA, Clements M, Musiime V, Moore DP, Sidat M, Mulenga V, Mutata C, Nalwanga D, Waggie Z, Chilundo J, Chabala C, Bwakura-Dangarembizi M, Archary M, Kiggwe A, Dangor Z, Spittle B, Kapasa M, Tagoola A, Jeki C, Sacarlal J, Buck WC, Chanda S, Mujuru HA,...

Performance of five risk stratification tools for paediatric pneumonia against WHO scores using data from the PediCAP trial in sub-Saharan Africa

Authors: Nalwanga D, Clements M, Musiime V, Mulenga V, Mujuru AH, Sidat M, Buck WC, Madhi AS, Bielicki AJ, Moore PD, Walker S, Sharland M PediCAP trial team Published in: medRxiv (Preprint)

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia

Authors: Rodriguez-Ruiz JP, Hiel S, Musiime V, Mulenga V, Mujuru HA, Madhi SA, Moore DP, Archary M, Clements M, Walker AS, Bielicki JA, Sharland M, Malhotra-Kumar S.
Published in: npj Antimicrobials and Resistance

Transição precoce para Amoxicilina oral: seguro e eficaz em crianças hospitalizadas com Pneumonia Grave

Presented by: Muhammad M. Sidat
Presented at: Jornadas Nacionais de Saude

Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP

Presented by: Muhammad M. Sidat, em nome da equipe do ensaio PediCAP
Presented at: Simpósio Pré-Evento, XIII Conferência Científica da UEM

Tolerability and Acceptability of Dispersible Oral Tablets of Amoxicillin and Co-Amoxiclav in African Children Hospitalized with Severe Pneumonia: Results from the PediCAP trial

Presented by: Sidat MM, on behalf of the PediCAP trial team
Presented at: INSPiRED 2025

Detection of respiratory pathogens in the nasopharynx of children hospitalised with severe pneumonia in sub-Saharan Africa

Presented by: P. Rodriguez-Ruiz, K. Loens, V. Musiime, M. Clements, S. Walker, J. Bielicki, M. Sharland, S. Malhotra-Kumar
Presented at: ESCMID Global 2025

The gastrointestinal resistome and microbiota of children hospitalised with severe pneumonia in sub-Saharan Africa in the PediCAP trial

Authors: P. Rodriguez-Ruiz, S. Hiel, V. Musiime, M. Clements, S. Walker, J. Bielicki, M. Sharland, S. Malhotra-Kumar
Presented at: ESCMID Global 2025

Early oral step-down to amoxicillin is safe and effective for children hospitalised with severe community-acquired pneumonia: the PediCAP trial

Presented by: Musiime V on behalf of the PediCAP trial team
Presented at: 20th UPA Annual Scientific Conference 2024

Impacto da passagem oral à Amoxicilina ou Co-amoxiclav e da duração da terapêutica antibiótica na eficácia, segurança e selecção da resistência antibiótica na Pneumonia severa infantil adquirida na comunidade (PAC) – ensaio clínico PediCAP

Authors: Issa F, Sidat M, Joaquim W, Maieca A, Massitela C, Adriano Q, Cassia U, Martins S, Chilundo J, Manjate N, Macanze E, Sigaúque A, Chilengue R, Bombe M, Florindo N, Nhacumba S, Buck WC, Sacarlal J, Musiime V, Sharland M, grupo do ensaio PediCAP
Presented at: Jornadas de AMOPE 2024